UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 264.50
-1.80 (-0.68%)
Feb 10, 2026, 2:45 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €50.6 billion as of February 10, 2026. Its market cap has increased by 40.84% in one year.
Market Cap
50.60B
Enterprise Value
51.86B
Revenue
6.85B
Ranking
n/a
PE Ratio
38.78
Stock Price
€264.50
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 50.60B, an increase of 5,580.69%. That is a compound annual growth rate of 13.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 50.60B | 11.61% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 42.94B |
| Financière de Tubize | 10.24B |
| Hyloris Pharmaceuticals | 207.20M |
| Onward Medical | 187.01M |
| European Medical Solutions | 22.68M |
| Celyad Oncology | 8.28M |
| BioSenic | 1.50M |
| Oxurion NV | 490.69K |